## Core Concept
Rifampicin is a key antibiotic used primarily in the treatment of tuberculosis. Its mechanism of action involves interfering with the bacterial RNA synthesis. Specifically, it targets the beta-subunit of the bacterial RNA polymerase enzyme.

## Why the Correct Answer is Right
The correct mechanism of action of rifampicin is that it **inhibits RNA synthesis** by binding to the beta-subunit of the bacterial RNA polymerase enzyme. This binding prevents the initiation of the RNA transcription process, effectively stopping the production of vital RNA molecules in the bacteria. This action is bactericidal, meaning it kills bacteria, which is crucial for the treatment of active tuberculosis.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because rifampicin does not work by inhibiting protein synthesis. That mechanism is characteristic of other antibiotics, such as tetracyclines and aminoglycosides.
- **Option B:** This option is incorrect as rifampicin's action is not related to inhibiting cell wall synthesis, which is how beta-lactam antibiotics (like penicillins and cephalosporins) work.
- **Option C:** Although this option might seem related because rifampicin does affect nucleic acid synthesis, the precise mechanism is through inhibiting RNA synthesis, not DNA synthesis. DNA synthesis inhibition is how certain other antibiotics and chemotherapeutic agents work.

## Clinical Pearl / High-Yield Fact
A critical point to remember is that **resistance to rifampicin can emerge rapidly** if it is used alone. Therefore, it is always used in combination with other antitubercular drugs to prevent the development of resistance. This combination therapy is a cornerstone of effective tuberculosis treatment.

## Correct Answer Line
**Correct Answer: D. Inhibits RNA synthesis.**